(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 18.38 | 18.50 | -0.65 | 18.38 | 18.50 | -0.65 | 69.74 | 61.59 | 13.23 |
| Other Income | 0.41 | 0.41 | 0.00 | 0.41 | 0.41 | 0.00 | 1.71 | 1.91 | -10.47 |
| PBIDT | 1.87 | 1.81 | 3.31 | 1.87 | 1.81 | 3.31 | 7.57 | 5.22 | 45.02 |
| Interest | 0.12 | 0.20 | -40.00 | 0.12 | 0.20 | -40.00 | 0.76 | 0.87 | -12.64 |
| PBDT | 1.75 | 1.61 | 8.70 | 1.75 | 1.61 | 8.70 | 6.81 | 4.35 | 56.55 |
| Depreciation | 0.32 | 0.50 | -36.00 | 0.32 | 0.50 | -36.00 | 2.01 | 1.91 | 5.24 |
| PBT | 1.43 | 1.11 | 28.83 | 1.43 | 1.11 | 28.83 | 4.80 | 2.44 | 96.72 |
| TAX | 0.33 | 0.28 | 17.86 | 0.33 | 0.28 | 17.86 | 1.41 | 0.38 | 271.05 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | -0.40 | -77.50 |
| PAT | 1.10 | 0.83 | 32.53 | 1.10 | 0.83 | 32.53 | 3.39 | 2.06 | 64.56 |
| Equity | 25.19 | 45.71 | -44.89 | 25.19 | 45.71 | -44.89 | 35.45 | 35.45 | 0.00 |
| PBIDTM(%) | 10.17 | 9.78 | 3.99 | 10.17 | 9.78 | 3.99 | 10.85 | 8.48 | 28.07 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1867.80 |
| Dr. Reddys Labs. | 1301.30 |
| Cipla | 1433.10 |
| Zydus Lifesciences | 1112.10 |
| Lupin | 2356.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: